Insulet Corp (PODD)
161.72
-5.53
(-3.31%)
USD |
NASDAQ |
Apr 25, 11:39
Insulet Cash from Financing (Quarterly): 2.20M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.20M |
| September 30, 2023 | -6.90M |
| June 30, 2023 | 3.20M |
| March 31, 2023 | -12.10M |
| December 31, 2022 | -14.50M |
| September 30, 2022 | -3.90M |
| June 30, 2022 | -1.60M |
| March 31, 2022 | -20.30M |
| December 31, 2021 | -1.50M |
| September 30, 2021 | 42.20M |
| June 30, 2021 | 28.40M |
| March 31, 2021 | -28.40M |
| December 31, 2020 | 130.10M |
| September 30, 2020 | 10.50M |
| June 30, 2020 | 483.90M |
| March 31, 2020 | -19.00M |
| December 31, 2019 | -202.40M |
| September 30, 2019 | 258.20M |
| June 30, 2019 | 16.20M |
| March 31, 2019 | 1.50M |
| December 31, 2018 | -1.619M |
| September 30, 2018 | 1.091M |
| June 30, 2018 | 0.698M |
| March 31, 2018 | -8.87M |
| December 31, 2017 | 297.85M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.456M |
| June 30, 2017 | 1.267M |
| March 31, 2017 | 2.927M |
| December 31, 2016 | -0.991M |
| September 30, 2016 | 182.15M |
| June 30, 2016 | -2.408M |
| March 31, 2016 | -2.184M |
| December 31, 2015 | -0.663M |
| September 30, 2015 | -0.956M |
| June 30, 2015 | -1.001M |
| March 31, 2015 | 2.249M |
| December 31, 2014 | 2.847M |
| September 30, 2014 | -30.89M |
| June 30, 2014 | 33.01M |
| March 31, 2014 | -0.939M |
| December 31, 2013 | 2.13M |
| September 30, 2013 | 1.089M |
| June 30, 2013 | 0.133M |
| March 31, 2013 | 93.04M |
| December 31, 2012 | 1.498M |
| September 30, 2012 | 1.435M |
| June 30, 2012 | 0.802M |
| March 31, 2012 | -0.347M |
| December 31, 2011 | 0.087M |
| September 30, 2011 | 1.18M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-202.40M
Minimum
Dec 2019
483.90M
Maximum
Jun 2020
34.96M
Average
-1.50M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Abbott Laboratories | -2.052B |
| Stryker Corp | -286.00M |
| Becton Dickinson & Co | -862.00M |
| Haemonetics Corp | 109.43M |
| Tandem Diabetes Care Inc | 2.617M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 45.20M |
| Cash from Investing (Quarterly) | -31.60M |
| Free Cash Flow | 36.50M |
| Free Cash Flow Per Share (Quarterly) | 0.1615 |
| Free Cash Flow to Equity (Quarterly) | 18.20M |
| Free Cash Flow to Firm (Quarterly) | 14.08M |
| Free Cash Flow Yield | 0.30% |